Your browser doesn't support javascript.
loading
[Treatment of patients with brain metastases from a melanoma]. / Prise en charge des patients atteints de métastases cérébrales de mélanome.
Modesto, A; Chira, C; Sol, J-C; Lubrano, V; Boulinguez, S; Pagès, C; Sibaud, V; Gomez-Roca, C; Moyal, É; Meyer, N.
Affiliation
  • Modesto A; Département de radiothérapie, institut Claudius-Regaud, institut universitaire du cancer de Toulouse-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France. Electronic address: modesto.anouchka@iuct-oncopole.fr.
  • Chira C; Département de radiothérapie, institut Claudius-Regaud, institut universitaire du cancer de Toulouse-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France.
  • Sol JC; Département de neurochirurgie, hôpital Purpan, CHU de Toulouse, 1, place Dr-Baylac, 31000 Toulouse, France; Unité Gamma Knife, hôpital Purpan, CHU de Toulouse, 1, place Dr-Baylac, 31000 Toulouse, France.
  • Lubrano V; Département de neurochirurgie, hôpital Purpan, CHU de Toulouse, 1, place Dr-Baylac, 31000 Toulouse, France; Unité Gamma Knife, hôpital Purpan, CHU de Toulouse, 1, place Dr-Baylac, 31000 Toulouse, France.
  • Boulinguez S; Département d'oncologie médicale, institut Claudius-Regaud, institut universitaire du cancer de Toulouse-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France.
  • Pagès C; Département d'oncologie médicale, institut Claudius-Regaud, institut universitaire du cancer de Toulouse-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France.
  • Sibaud V; Département d'oncologie médicale, institut Claudius-Regaud, institut universitaire du cancer de Toulouse-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France.
  • Gomez-Roca C; Département d'oncodermatologie, institut universitaire du cancer de Toulouse-Oncopole, CHU de Toulouse, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France.
  • Moyal É; Département de radiothérapie, institut Claudius-Regaud, institut universitaire du cancer de Toulouse-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France; Unité Gamma Knife, hôpital Purpan, CHU de Toulouse, 1, place Dr-Baylac, 31000 Toulouse, France.
  • Meyer N; Département d'oncologie médicale, institut Claudius-Regaud, institut universitaire du cancer de Toulouse-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France.
Cancer Radiother ; 23(2): 147-150, 2019 Apr.
Article in Fr | MEDLINE | ID: mdl-30904418
Whereas immune checkpoint inhibitors of serine/threonine protein kinase B-raf therapy dramatically changed metastatic outcomes of patients with melanoma, they remain at high risk of brain extension. Additional local treatment can be offered in this situation such as surgery and or stereotactic radiotherapy. In this review article, we describe the different options with published data and their optimal timing.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Melanoma Type of study: Etiology_studies Limits: Humans Language: Fr Journal: Cancer Radiother Journal subject: NEOPLASIAS / RADIOTERAPIA Year: 2019 Document type: Article Country of publication: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Melanoma Type of study: Etiology_studies Limits: Humans Language: Fr Journal: Cancer Radiother Journal subject: NEOPLASIAS / RADIOTERAPIA Year: 2019 Document type: Article Country of publication: France